Monoclonal Antibody Based Products
489 pages | Octobre 2005 |
This report analyzes the worldwide markets for Monoclonal Antibody Based Products in Millions of US$.
The major product segments analyzed are Therapeutics, and Diagnostics.
The sub product segme |
2 308,00 €
|
| |
| |
Countries with the Highest Prevalence of HIV/AIDS
1 pages | Janvier 2006 |
This Database Table is a one-page table of hard-to-find numerical information.
The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif |
80,00 €
|
| |
| |
Therapeutic Vaccines: More Trials and Tribulations
202 pages | Décembre 2005 |
IntroductionTherapeutic vaccines have faced numerous setbacks in recent years.
The only three vaccines to reach the market have had insignificant sales, while the pipeline has seen numerous high-pr |
6 460,00 €
|
| |
| |
Chinese Markets for Vaccine
200 pages | Août 2003 |
China's demand for vaccine has grown at a fast pace in the past decade.
In the next five years, both production and demand will continue to grow.
This new study examines China's economic trends, |
2 835,00 €
|
| |
| |
PharmaVitae 2005: MedImmune Global Analysis
79 pages | Juillet 2005 |
IntroductionThis analysis examines the market position and future outlook for MedImmune.
The profile encompasses company strategy, portfolio and pipeline analysis and assessment of financial perfor |
3 040,00 €
|
| |
| |
Stakeholder Opinions: Sexually Transmitted Infections - The Silent Menace
118 pages | Novembre 2005 |
IntroductionThe global incidence of STIs is estimated at several hundreds of millions cases per year, and due to the asymptomatic nature of most infections, underreporting is likely to mask the real i |
3 230,00 €
|
| |
| |
Drugs and Vaccines in Development of Infectious Diseases, 2004
1 pages | Janvier 2006 |
This Database Table is a one-page table of hard-to-find numerical information.
The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif |
80,00 €
|
| |
| |
Stakeholder Perspectives: Influenza Vaccines - Flying back Into Flu
166 pages | Décembre 2005 |
IntroductionInfluenza is a highly infectious disease which globally infects 10-20% of the population every year causing up to 500,000 deaths.
Although all persons are at risk, the elderly and the y |
6 460,00 €
|
| |
| |
Pipeline Insight: HIV - Hold Your Horses
216 pages | Avril 2005 |
IntroductionIn the current antiretroviral landscape, resistance in all three of the established classes is proving to be problematic.
Accordingly, current clinical trials are recruiting treatment-r |
9 120,00 €
|
| |
| |
Pipeline Insight: Hepatitis B - New Kids on the Block
211 pages | Avril 2005 |
IntroductionAccording to the WHO, 350-400 million people are chronically infected with HBV progresses to liver cirrhosis and hepatocellular carcinoma.
Previously HBV has been treated with lamivudin |
9 120,00 €
|
| |
| |
